Analyst Price Target is $24.17
▲ +56.01% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Avadel Pharmaceuticals in the last 3 months. The average price target is $24.17, with a high forecast of $29.00 and a low forecast of $21.00. The average price target represents a 56.01% upside from the last price of $15.49.
Current Consensus is
Buy
The current consensus among 6 contributing investment analysts is to buy stock in Avadel Pharmaceuticals. This Buy consensus rating has held steady for over two years.